Company Focus
Overview
Price Chart
Key Metrics
Valuation
Financials
Earnings
Dividends
Analyst Ratings
Insider Trades
Events Timeline
News + Sentiment
Peer Comparison
enCore Energy
EU Micro CapEnergy · Uranium
Updated: May 22, 2026, 22:06 UTC
Key Metrics
Valuation Analysis
About the Company
enCore Energy Corp., together with its subsidiaries, engages in the acquisition, exploration, development, and extraction of uranium resource properties in the United States. The company is headquartered in Dallas, Texas.
enCore Energy Stock at a Glance
enCore Energy (EU) is currently trading at $1.48 with a market capitalization of $287.5M. The 52-week range spans from $1.34 to $4.18; the current price is 64.6% below the yearly high. Year-over-year revenue growth stands at +0.3%.
💰 Dividend
enCore Energy currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Analyst Rating
4 analysts rate enCore Energy (EU) on consensus: Strong Buy. The average price target is $3.81, implying +157.47% from the current price. Analyst price targets range from $2.99 to $4.48.
Investment Thesis: Strengths & Weaknesses
- Analyst consensus: Strong Buy
- Solid balance sheet with low debt (D/E 40.38)
- –Currently unprofitable
- –High short interest (12.12%)
- –Negative free cash flow
Technical Snapshot
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Risk Profile
The data points to market-like volatility, elevated short interest (12.12%).
Trading Data
Related Stocks in the Same Sector
enCore Energy at 1.52 dollars: the US uranium ISR producer at the nexus of nuclear renaissance and supply security
The Real Story
enCore Energy is a US-domiciled uranium miner using in-situ recovery (ISR) — pumping a leaching solution underground to dissolve uranium ore in place rather than digging open pits. ISR is lower-cost and lower-environmental-footprint than conventional uranium mining, and is the dominant production method in the United States and Kazakhstan. enCore operates the Rosita and Alta Mesa ISR plants in Texas and has development projects in Wyoming and New Mexico.
The market is split on EU. Bulls see the structural uranium-renaissance story: AI data centers driving electricity demand, SMR (small modular reactor) and nuclear-reactor restart plans (Three Mile Island Unit 1, Palisades, Duane Arnold), and a US Department of Energy policy of de-Russification of uranium supply. Bears see a tiny operator with revenue 43 million USD, EV/Sales 7.5, negative EBITDA, and binary execution risk on Wyoming projects.
What Smart Money Thinks
Mega Uranium (Canadian uranium-fund) and Sprott Physical Uranium Trust have related-party exposure. No major US 13F whale beyond passive indexers. Insiders including CEO Paul Goranson hold meaningful stakes. The company periodically does equity raises to fund development — typical of junior uranium.
Explore the BMI Smart-Money Tracker →
📈 The 3 Real Bull Points
📉 The 3 Real Bear Points
Valuation in Context
At 1.52 USD the trailing P/E and forward P/E are negative — EU is pre-profitability. EV/Sales 7.5 and P/B 1.16 reflect uranium-renaissance hype priced in. The thesis is leverage to uranium price: if spot stays above 80 USD per pound, EU's economics support a multi-bagger; if it falls below 50 USD, current operations barely cover cash costs.
🗓️ Next 3 Catalyst Dates
- :
- :
- :
💬 Daniel's Take
EU is a uranium-renaissance leverage play, not a value stock. I would only own this in a uranium basket alongside Cameco, Yellow Cake, Sprott Physical Uranium Trust — diversifying the binary risk on any single junior. Size 0.3 to 0.5 percent as part of a uranium-basket thematic if you want the exposure. Avoid concentrating because junior uranium executions slip, dilution happens, and the price-sensitivity is extreme.
Sources (3)
Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.
Where can I buy enCore Energy?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
